Adrian Isaac Campos Gonzalez

Adrian Isaac Campos Gonzalez

Auto-generated profile, based on publicly available information

Adrian Isaac Campos Gonzalez

Regeneron Genetics Center, Tarrytown, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2024 in Nature Genetics
Verified
Journal Article
Open access
PDF file
XMXiangrui Meng
Xiangrui Meng
GNGeorgina Navoly
Georgina Navoly
OGOlga Giannakopoulou
Olga Giannakopoulou
DLDaniel Levey
Daniel Levey
DKDora Koller
Dora Koller
BPBioBank Japan Project
BioBank Japan Project
Most genome-wide association studies (GWAS) of major depression (MD) have been conducted in samples of European ancestry. Here we report a multi-ancestry GWAS of MD, adding data from 21 cohorts with 88,316 MD cases and 902,757 controls to previously reported data. This analysis used a range of measures to define MD and included samples of African (36% of effective sample size), East Asian (26%) and South Asian (6%) ancestry and Hispanic/Latin American participants (32%). The multi-ancestry GWAS identified 53 significantly associated novel loci. For loci from GWAS in European ancestry samples, fewer than expected were transferable to other ancestry groups. Fine mapping benefited from additional sample diversity. A transcriptome-wide association study identified 205 significantly associated novel genes. These findings suggest that, for MD, increasing ancestral and global diversity in genetic studies may be particularly important to ensure discovery of core genes and inform about transferability of findings.

14 February 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
ACAdrián I. Campos
Adrián I. Campos
LGLuis M. García-Marín
Luis M. García-Marín
EBEnda M. Byrne
Enda M. Byrne
NMNicholas G. Martin
Nicholas G. Martin
GCGabriel Cuéllar-Partida
Gabriel Cuéllar-Partida
MRMiguel E. Rentería
Miguel E. Rentería
Although snoring is common in the general population, its aetiology has been largely understudied. Here we report a genetic study on snoring (n ~ 408,000; snorers ~ 152,000) using data from the UK Biobank. We identify 42 genome-wide significant loci, with an SNP-based heritability estimate of ~10% on the liability scale. Genetic correlations with body mass index, alcohol intake, smoking, schizophrenia, anorexia nervosa and neuroticism are observed. Gene-based associations identify 173 genes, including DLEU7, MSRB3 and POC5, highlighting genes expressed in the brain, cerebellum, lungs, blood and oesophagus. We use polygenic scores (PGS) to predict recent snoring and probable obstructive sleep apnoea (OSA) in an independent Australian sample (n ~ 8000). Mendelian randomization analyses suggest a potential causal relationship between high BMI and snoring. Altogether, our results uncover insights into the aetiology of snoring as a complex sleep-related trait and its role in health and disease beyond it being a cardinal symptom of OSA.

15 April 2021 in Nature Human Behaviour
Verified
Journal Article
Closed access
PDF file
JTJackson G. Thorp
Jackson G. Thorp
ACAdrian I. Campos
Adrian I. Campos
AGAndrew D. Grotzinger
Andrew D. Grotzinger
ZGZachary F. Gerring
Zachary F. Gerring
JAJiyuan An
Jiyuan An
EDEske M. Derks
Eske M. Derks

16 June 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ACAdrian I. Campos
Adrian I. Campos
KVKarin J. H. Verweij
Karin J. H. Verweij
DSDixie J. Statham
Dixie J. Statham
PMPamela A. F. Madden
Pamela A. F. Madden
DMDominique F. Maciejewski
Dominique F. Maciejewski
MRMiguel E. Rentería
Miguel E. Rentería
Family studies have identified a heritable component to self-harm that is partially independent from comorbid psychiatric disorders. However, the genetic aetiology of broad sense (non-suicidal and suicidal) self-harm has not been characterised on the molecular level. In addition, controversy exists about the degree to which suicidal and non-suicidal self-harm share a common genetic aetiology. In the present study, we conduct genome-wide association studies (GWAS) on lifetime self-harm ideation and self-harm behaviour (i.e. any lifetime self-harm act regardless of suicidal intent) using data from the UK Biobank (n > 156,000). We also perform genome wide gene-based tests and characterize the SNP heritability and genetic correlations between these traits. Finally, we test whether polygenic risk scores (PRS) for self-harm ideation and self-harm behaviour predict suicide attempt, suicide thoughts and non-suicidal self-harm (NSSH) in an independent target sample of 8,703 Australian adults. Our GWAS results identified one genome-wide significant locus associated with each of the two phenotypes. SNP heritability (hsnp2) estimates were ~10%, and both traits were highly genetically correlated (LDSC rg > 0.8). Gene-based tests identified seven genes associated with self-harm ideation and four with self-harm behaviour. Furthermore, in the target sample, PRS for self-harm ideation were significantly associated with suicide thoughts and NSSH, and PRS for self-harm behaviour predicted suicide thoughts and suicide attempt. Follow up regressions identified a shared genetic aetiology between NSSH and suicide thoughts, and between suicide thoughts and suicide attempt. Evidence for shared genetic aetiology between NSSH and suicide attempt was not statistically significant.

1 August 2021 in Biological Psychiatry
Verified
Journal Article
Closed access
ACAdrian I. Campos
Adrian I. Campos
PTPaul M. Thompson
Paul M. Thompson
DVDick J. Veltman
Dick J. Veltman
EPElena Pozzi
Elena Pozzi
LVLaura S. van Veltzen
Laura S. van Veltzen
MRMiguel E. Rentería
Miguel E. Rentería

9 November 2021 in Communications Medicine
Verified
Journal Article
Open access
PDF file
ACAdrian I. Campos
Adrian I. Campos
AMAoibhe Mulcahy
Aoibhe Mulcahy
JTJackson G. Thorp
Jackson G. Thorp
NWNaomi R. Wray
Naomi R. Wray
EBEnda M. Byrne
Enda M. Byrne
MRMiguel E. Rentería
Miguel E. Rentería
Background: Major depression is one of the most disabling health conditions internationally. In recent years, new generation antidepressant medicines have become very widely prescribed. While these medicines are efficacious, side effects are common and frequently result in discontinuation of treatment. Compared with specific pharmacological properties of the different medications, the relevance of individual vulnerability is understudied. Methods: We used data from the Australian Genetics of Depression Study to gain insights into the aetiology and genetic risk factors to antidepressant side effects. To this end, we employed structural equation modelling, polygenic risk scoring and regressions. Results: Here we show that participants reporting a specific side effect for one antidepressant are more likely to report the same side effect for other antidepressants, suggesting the presence of shared individual or pharmacological factors. Polygenic risk scores (PRS) for depression associated with side effects that overlapped with depressive symptoms, including suicidality and anxiety. Body Mass Index PRS are strongly associated with weight gain from all medications. PRS for headaches are associated with headaches from sertraline. Insomnia PRS show some evidence of predicting insomnia from amitriptyline and escitalopram. Conclusions: Our results suggest a set of common factors underlying the risk for antidepressant side effects. These factors seem to be partly explained by genetic liability related to depression severity and the nature of the side effect. Future studies on the genetic aetiology of side effects will enable insights into their underlying mechanisms and the possibility of risk stratification and prophylaxis strategies.